Home
overview

SMi Group’s 8th annual conference on Parallel Trade returns in 2014. The event will cover the latest regulation in the industry and offer guidance on compliance and best practice. Anti-counterfeiting and competition law; building best practice processes; effective supply chain management; and differing perspectives from throughout the supply chain are just a selection of topics which will be featured. Leading pharmaceutical companies, legislative bodies and many more will be speaking about their challenges and practical solutions to minimise loss and drive business performance. The event represents an excellent means for knowledge sharing and learning about case studies across the industry.

Senior management personnel will be speaking about their successes and analysing recent cases. This event promises to be a high quality practical event with plenty of opportunity for debate and offers you step-by-step guidance on the complex issue of parallel trade.

2013 testimonials

‘Good topics, up to date’ Novartis Pharma AG
‘Janice Haigh’s workshop was excellent’ Merck
‘Thought provoking, high energy and relevant’ Ernst and Young LLP
‘Very interesting, really good speakers’ AstraZeneca
 

This 2 day event represents an excellent opportunity for delegates to hear from leading experts. Professionals from across the pharmaceutical industry and beyond will be in attendance. The diverse selection of speakers and delegates from around the world will give added value to this event, helping you manage your challenges and drive forward your solutions in a different and effective way. There will be unrivalled networking opportunities and space to reflect on your current business challenges.
 

Attend this event and learn the following:

  • understanding legal parallel trade and the non-licensed supply chain
  • challlenge the differing perspectives on parallel trade
  • scrutinise effective supply chain management
  • analyse how to build best practice processes driven by the impact of parallel trade

 

 

 

 Commercial Development Director

 Director of Anti-Counterfeiting

 European Distribution and Customer Services Leader  Parallel Import Manager
 Operational Pricing and Planning  Export Manager
 Channel Manager  Law Partners
 Head of International Sales  Health Regulators
 Heads of Market Access  Global Asset Leads
 Business Intelligence Manager  Health Economists
 Head of Commercial Supply Chain  Finance Directors
 Head of Pricing and Reimbursement  Business Analyst
Financial Planning and Analysis  Directors of Packaging

 

 

 

Delegates from the following companies attended the event in 2013:

Abbott Healthcare products; Alfa Wassermann; Amgen ; Amgen Europe BV; Amgen Ltd; Arnold and Porter; Astellas Pharma Europe; AstraZeneca; Biogen IDEC International GmbH; Boehringer-Ingelheim; BTG plc; Chiesi Farmaceutici SpA; Clinuvel; Covington & Burling Belgium; Delfarma; Eli Lilly Suisse SA; Europe Economics; European Alliance for Access to Safe Medicines; European Association of Euro-Pharmaceutical Companies ; Grunenthal Gmbh; GS1; GSK; H Lundbeck A/S; IMS Health; Kantar Health GmbH; LEO Pharma; MD Pharma SA; Medivir AB; Merck Export GmbH; Merck Romania SRL; Merck Rumania; Norgine Limited; Novartis Pharma AG; Novartis UK; Profile Pharma Ltdd; Shire Pharmaceuticals; Shire Pharmaceuticals Group Plc; Sussex University; Takeda; Teva UK Ltd; UCB Pharma; University Of East Anglia; University of Ferrara; White & Case LLP.

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Eric Noehrenberg

Eric Noehrenberg , Director, Public Affairs for Market Access, Shire Pharmaceuticals Group Plc

9:10 Overview of parallel trade and its impact

Eric Noehrenberg

Eric Noehrenberg , Director, Public Affairs for Market Access, Shire Pharmaceuticals Group Plc

 

  • Why is it happening?
  • Contrasting perspectives on the phenomenon
  •  How to approach parallel trade going forward
  • 9:50 Parallel trade - its birth, development and future

    Suzanne Elvidge

    Suzanne Elvidge, Specialised writer in healthcare, pharmaceuticals and business, None

    10:30 Morning Coffee

    10:50 What the Falsified Medicines Directive means for parallel trade

    Craig Stobie

    Craig Stobie, Global Life Sciences Sector Manager, Domino Uk Limited

     

  • Considering the building blocks of current legislation
  • How to get a compliant product to market – evaluating the impact of 2014 legislation on the pharmaceutical industry
  • Parallel traders as manufacturers – where you sell product versus making product – simplifying the conundrum
  • Revealing the hidden challenges of serialisation and traceability
  • 11:30 Falsified Medicines Directive - implementing safety features

    Maarten Van Baelen

    Maarten Van Baelen, Medical Affairs Manager, European Generic Medicines Association

     

  • Costs for the generic medicines industry
  • Risks for the supply chain
  • Setting up repository systems
  • 12:10 Networking Lunch

    13:30 Parallel trade and competition law - an update

    Strati Sakellariou

    Strati Sakellariou, Associate, White & Case LLP

  • Why is competition law relevant?
  • The European Commission’s renewed interest in parallel trade
  • Update on national developments
  • 14:10 Parallel trade within the EU - A competition policy viewpoint

    Lluis Sauri-Romero

    Lluis Sauri-Romero, Economist, European Commission

    14:50 Falsified Medicines - where are we now?

    Mike Isles

    Mike Isles, Executive Director, European Alliance for Access to Safe Medicines

    15:30 Imports from new member states and the specific mechanism

    Christopher Stothers

    Christopher Stothers, Partner, Arnold and Porter

     

  • When and why can patents be asserted against imports within the EEA?
  • Exploring Merck v Sigma: UK judgments and reference to ECJ
  • Discussion of practical implications going
  • 16:10 Chairman’s Closing Remarks and Close of Day One

    16:25 Afternoon Tea

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    Eric Noehrenberg

    Eric Noehrenberg , Director, Public Affairs for Market Access, Shire Pharmaceuticals Group Plc

    9:10 Parallel trade as part of pricing strategy

    Janice Haigh

    Janice Haigh, Practice Leader, Market Access, Quintiles (UK) Ltd

  • How should parallel trade be managed as part of a global pricing strategy?
  • How can we implement dual pricing strategies?
  • How narrow does the price corridor need to be?
  • What other price strategies should we consider?
  • 9:50 Initiatives of parallel distributors in the context of the Falsified Medicines Directive

    Tomasz Dzitko

    Tomasz Dzitko, Founder and CEO , Delfarma

  • Good parallel distribution guidelines
  • Discussing the early warning anti-counterfeit platform
  • Joint Audits initiative
  • Collaboration with other stakeholders
  • 10:30 Morning Coffee

    10:50 Shortages of medicines and parallel trade

    Dimitrios Karageorgiou

    Dimitrios Karageorgiou, Secretary General, Panhellenic Pharmacists Association

     

  • Description of the current situation – the reality of functioning at the edge of the humanitarian crisis in the health sector
  •  Analysis of the factors causing shortages of medicines
  • Transformations and structural changes affecting the normality of the pharmaceutical market, social behaviours and the role of media propaganda
  • Pharmacists within and against parallel trade
  • 11:30 The impact of parallel imports on social welfare

    Moritz  Suppliet

    Moritz Suppliet, Doctoral Researcher, Dusseldorf Institute for Competition Economics

    12:10 Networking Lunch

    13:30 Panel discussion - challenges in the local market and internationally

    Peter Sinis

    Peter Sinis, Decision Support, Biogen IDEC International GmbH

    Tim Hammond

    Tim Hammond, Head of Global Pricing, LEO Pharma

    Don Macarthur

    Don Macarthur, Independent Global Pharmaceutical Business Analyst, JustPharmaReports

    14:10 Interpreting the Specific Mechanism

    Martin Paltnoi

    Martin Paltnoi, CEO, MPA Business Services Ltd

     

  • Background to the Specific Mechanism
  • (a) Countries effected
  • (b) Legal Provisions
  • (c) Spirit of the Specific Mechanism
  • Key patent/SPC law dates
  • Specific Mechanism - Patent/SPC illustration
  • What patents are relevant?
  • Merck vs Sigma case
  • Croatian perspective
     

     

     

     

  • 14:50 Chairman’s Closing Remarks and Close of Day Two

    15:00 Afternoon Tea

    +

    FEATURED SPEAKERS

    Dimitrios Karageorgiou

    Dimitrios Karageorgiou

    Secretary General, Panhellenic Pharmacists Association
    Eric Noehrenberg

    Eric Noehrenberg

    Director, Public Affairs for Market Access, Shire Pharmaceuticals Group Plc

    Christopher Stothers

    Partner, Arnold and Porter
    Christopher Stothers

    Craig Stobie

    Global Life Sciences Sector Manager, Domino Uk Limited
    Craig Stobie

    Dimitrios Karageorgiou

    Secretary General, Panhellenic Pharmacists Association
    Dimitrios Karageorgiou

    Don Macarthur

    Independent Global Pharmaceutical Business Analyst, JustPharmaReports
    Don Macarthur

    Eric Noehrenberg

    Director, Public Affairs for Market Access, Shire Pharmaceuticals Group Plc
    Eric Noehrenberg

    Janice Haigh

    Practice Leader, Market Access, Quintiles (UK) Ltd
    Janice Haigh

    Lluis Sauri-Romero

    Economist, European Commission
    Lluis Sauri-Romero

    Maarten Van Baelen

    Medical Affairs Manager, European Generic Medicines Association
    Maarten Van Baelen

    Martin Paltnoi

    CEO, MPA Business Services Ltd
    Martin Paltnoi

    Mike Isles

    Executive Director, European Alliance for Access to Safe Medicines
    Mike Isles

    Moritz Suppliet

    Doctoral Researcher, Dusseldorf Institute for Competition Economics
    Moritz  Suppliet

    Peter Sinis

    Decision Support, Biogen IDEC International GmbH
    Peter Sinis

    Strati Sakellariou

    Associate, White & Case LLP
    Strati Sakellariou

    Suzanne Elvidge

    Specialised writer in healthcare, pharmaceuticals and business, None
    Suzanne Elvidge

    Tim Hammond

    Head of Global Pricing, LEO Pharma
    Tim Hammond

    Tomasz Dzitko

    Founder and CEO , Delfarma
    Tomasz Dzitko

    Workshops

    Parallel trade management strategies
    Workshop

    Parallel trade management strategies

    Marriott Regents Park
    12th February 2014
    London, United Kingdom

    Interview with Chair – Dr Eric Noehrenberg

    Download

    Marriott Regents Park

    128 King Henry's Road
    London NW3 3ST
    United Kingdom

    Marriott Regents Park

    This 4 star north London hotel in zone 2 is the perfect destination for the astute business traveler as well as the leisure guest that knows how convenient north London hotels are, as a base from which to explore the city .Bond Street is just 3 stops from Swiss Cottage underground station on the Jubilee Line, so you can be shopping, exploring the sights and taking in one of London’s world-renowned West End shows in less than 15 minutes when you stay at this hotel near central London. At the same time, the hive of activity that is Camden Town, the chic shops, cafes and restaurants of Primrose Hill and ZSL’s London Zoo in Regents Park are all just a short walk from this hotel in north London.

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.